ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Kite, A Gilead Company · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
multiple-sclerosis
chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, multiple sclerosis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 870769
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.